PMID- 32967115 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201028 IS - 2223-7747 (Print) IS - 2223-7747 (Electronic) IS - 2223-7747 (Linking) VI - 9 IP - 9 DP - 2020 Sep 21 TI - Bio-Guided Fractionation Driven by In Vitro alpha-Amylase Inhibition Assays of Essential Oils Bearing Specialized Metabolites with Potential Hypoglycemic Activity. LID - 10.3390/plants9091242 [doi] LID - 1242 AB - Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by unpaired blood glycaemia maintenance. T2DM can be treated by inhibiting carbohydrate hydrolyzing enzymes (alpha-amylases and alpha-glucosidases) to decrease postprandial hyperglycemia. Acarbose and voglibose are inhibitors used in clinical practice. However, these drugs are associated with unpleasant gastrointestinal side effects. This study explores new alpha-amylase inhibitors deriving from plant volatile specialized metabolites. Sixty-two essential oils (EOs) from different plant species and botanical families were subjected to alpha-amylase in vitro enzymatic assay and chemically characterized using gas chromatography coupled to mass spectrometry. Several EOs were found to be potential alpha-amylase inhibitors, and Eucalyptus radiata, Laurus nobilis, and Myristicafragrans EOs displayed inhibitory capacities comparable to that of the positive control (i.e., acarbose). A bio-guided fractionation approach was adopted to isolate and identify the active fractions/compounds of Eucalyptus radiata and Myristica fragrans EOs. The bio-guided fractionation revealed that EOs alpha-amylase inhibitory activity is often the result of antagonist, additive, or synergistic interactions among their bioactive constituents and led to the identification of 1,8-cineole, 4-terpineol, alpha-terpineol, alpha-pinene, and beta-pinene as bioactive compounds, also confirmed when they were tested singularly. These results demonstrate that EO oils are a promising source of potential alpha-amylase inhibitors. FAU - Capetti, Francesca AU - Capetti F AUID- ORCID: 0000-0002-1024-7088 AD - Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy. FAU - Cagliero, Cecilia AU - Cagliero C AUID- ORCID: 0000-0003-3512-6124 AD - Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy. FAU - Marengo, Arianna AU - Marengo A AD - Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy. FAU - Bicchi, Carlo AU - Bicchi C AUID- ORCID: 0000-0003-1782-7357 AD - Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy. FAU - Rubiolo, Patrizia AU - Rubiolo P AD - Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy. FAU - Sgorbini, Barbara AU - Sgorbini B AUID- ORCID: 0000-0001-6848-1304 AD - Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy. LA - eng PT - Journal Article DEP - 20200921 PL - Switzerland TA - Plants (Basel) JT - Plants (Basel, Switzerland) JID - 101596181 PMC - PMC7569863 OTO - NOTNLM OT - Eucalyptus radiata OT - Myristica fragrans OT - bio-guided fractionation OT - essential oil OT - alpha-amylase inhibition COIS- The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. EDAT- 2020/09/25 06:00 MHDA- 2020/09/25 06:01 PMCR- 2020/09/21 CRDT- 2020/09/24 01:01 PHST- 2020/08/21 00:00 [received] PHST- 2020/09/17 00:00 [revised] PHST- 2020/09/19 00:00 [accepted] PHST- 2020/09/24 01:01 [entrez] PHST- 2020/09/25 06:00 [pubmed] PHST- 2020/09/25 06:01 [medline] PHST- 2020/09/21 00:00 [pmc-release] AID - plants9091242 [pii] AID - plants-09-01242 [pii] AID - 10.3390/plants9091242 [doi] PST - epublish SO - Plants (Basel). 2020 Sep 21;9(9):1242. doi: 10.3390/plants9091242.